Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pharma VAM
Saint Petersburg, Russia
- Ownership
- Private
- Employees
- ~35
- Development stage
- Other
01
Overview
Pharma VAM is a Russian biotechnology company founded in 1994, specializing in the development and manufacture of original peptide-based bioregulators. The company's core innovation centers on a "basic regulatory molecule" designed to activate the body's natural defense mechanisms to treat infectious and non-infectious diseases. Its lead commercial products, Glutoxim and Molixan, are used as immunomodulators and cytoprotectors in the treatment of tuberculosis, viral hepatitis, psoriasis, and as adjuncts in oncology. Pharma VAM is an active member of the AMR Industry Alliance, contributing to global efforts against antimicrobial resistance through its innovative therapeutic strategies.
- Therapeutic areas
- OncologyDermatologyInfectious Diseases
- Modalities
- PeptidesSmall molecule
- Industry
- Biotech
02
Partnerships
AMR Industry Alliance
Beyond the preview
Go deeper on Pharma VAM.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Pharma VAM.